Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Intervention:  Other: fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  2. Total Marrow Irradiation for Refractory Acute Leukemia

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Intervention:  Drug: cyclophosphamide 60 mg/kg/day intravenous x 2 days pre-transplant, total ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  3. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... Alemtuzumab Cyclophosphamide Fludarabine ... Thiotepa metabolism. Other Name: Thioplex Drug: Cyclophosphamide Cyclophosphamide (Cytoxan) should be infused over one ...

    Clinical Trial last updated 04/28/2016 - 8:36am.

  4. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... with CD20+ malignancies. Other Name: Rituxan Drug: Cyclophosphamide 50 mg/kg by vein on Day -6. Other Names: ... Alkeran Drug: Mesna Mesna by vein on Day -6, after cyclophosphamide to help lower the risk of side effects to the bladder. ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  5. Clinical Trials Report for August 2015

    ... non-myeloablative conditioning and post transplantation cyclophosphamide with partially HLA -mismatched donors. This ...

    Page last updated 07/30/2015 - 8:45am.

  6. T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (MOHEL)

    ... Alemtuzumab Cyclophosphamide Phase:  ... day-5 3 g/m2 q 12 hours Other Name: cytarabine Drug: Cyclophosphamide day-7 and day-6 45 mg/kg Other Name: Cytoxan Biological: ...

    Clinical Trial last updated 04/28/2016 - 12:15pm.

  7. Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

    ... mg/m2 as a 24 hour continuous infusion started on day -4. Cyclophosphamide 60 mg/kg/day IV given over 1 hour daily on days -3, -2. Drug: ... mg/m2 as a 24 hour continuous infusion started on day -4. Cyclophosphamide 60 mg/kg/day IV given over 1 hour daily on days -3 and ...

    Clinical Trial last updated 05/03/2016 - 11:31am.

  8. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    ... through -2: 30 mg/m^2 IV daily Other Name: Fludara Drug: Cyclophosphamide Days -6 through -5: 14.5 mg/kg IV daily Other ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  9. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... 6 days before transplant Fludarabine (chemotherapy) Cyclophosphamide (chemotherapy) 5 days before transplant Fludarabine Thiotepa 4 ... transplant Fludarabine 6 days before transplant Fludarabine Cyclophosphamide 5 days before transplant Fludarabine Cyclophosphamide 4 days ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  10. Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

    ... Intervention:  Drug: Cyclophosphamide,Campath IH and TBI DAY 5 TREATMENT 6 5 CYTOXAN 50 ...

    Clinical Trial last updated 04/26/2016 - 10:05am.